Agios Pharmaceuticals, Inc. (AGIO)
$31.81-0.34%Close
SELLRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.9B
- Beta
- 0.63
- P/E (TTM)
- -4.52
- Short % float
- 12.60%
- Days to cover
- 6.4
- SI change
- -7.2%
- 1W
- +0.03%
- 1M
- -5.44%
- vs SPY 1W
- -1.13%
- vs SPY 1M
- -8.43%
Industry peers
FMP comparable companies · ranked by market cap
- PTCTSELLPTC Therapeutics, Inc.$5.2BRECOVERYQ 18$62.56+3.42%
- MIRMSELLMirum Pharmaceuticals, Inc.$5.0BRECOVERYQ 37$81.35+5.73%
- IRONSELLDisc Medicine, Inc.$2.3BCRISISQ 1$60.77+2.12%
- BCRXSELLBioCryst Pharmaceuticals, Inc.$2.1BRECOVERYQ 6$8.29+3.14%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$15.29+1.24%
- PHARSELLPharming Group N.V.$675MCRISISQ -1$9.53+2.73%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 9
- GROWTH
- 19
- GARP
- 7
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-21.4%
REV YoY-
ROE-35.7%
EPS YoY-
ROA-37.1%
GROSS88
OP-467
NET-418
[VALUATION]
P/E TTM-4.52
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B1.84
P/FCF-
EV/EBITDA-4.38
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.04
ALTMAN Z-
CURR RATIO10.22
ND/EBITDA-
BETA0.63
Company news
FAQ
- What is LOPJLB’s current signal on AGIO?
- LOPJLB’s latest quantitative signal on Agios Pharmaceuticals, Inc. (AGIO) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is AGIO in?
- Agios Pharmaceuticals, Inc. (AGIO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Agios Pharmaceuticals, Inc. (AGIO) do?
- Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Addition…